Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]

• Main Authors: Tan X, Kim HS, Baugh K, Huang Y, Kadiyala N, Wences M, Singh N, Wenzler E, Bulman ZP
• Format: Article
• Language: English
• Published: Dove Medical Press 2021-02-01
• Series: Infection and Drug Resistance
• Subjects: metallo-β-lactamase; enterobacterales; carbapenemase; ceftazidime-avibactam; aztreonam; rapid diagnostics
• Online Access: https://www.dovepress.com/corrigendum-therapeutic-options-for-metallo-beta-lactamase-producing-e-peer-reviewed-article-IDR

Tan X, Kim HS, Baugh K, et al. Infect Drug Resist.2021;14:125–142.  Page 134, left column, second paragraph, fourth sentence from the bottom, the text “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration- dependent plasma protein binding ranging from 70% to 90% (except eravacycline is 21%), and exhibit minimal renal clearance” should read “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration- dependent plasma protein binding ranging from 70% to 90% (except omadacycline is 21%), and exhibit minimal renal clearance”. The authors apologize for this error. Read the original article